PNC Financial Services Group Inc. Sells 16,651 Shares of Becton, Dickinson and Company (BDX)

PNC Financial Services Group Inc. cut its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 4.5% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 356,287 shares of the medical instruments supplier’s stock after selling 16,651 shares during the period. PNC Financial Services Group Inc. owned approximately 0.17% of Becton, Dickinson and worth $69,516,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Almanack Investment Partners LLC. acquired a new position in shares of Becton, Dickinson and in the 1st quarter valued at approximately $105,000. Parkside Financial Bank & Trust raised its position in shares of Becton, Dickinson and by 1.4% in the 1st quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock valued at $116,000 after purchasing an additional 9 shares in the last quarter. QCI Asset Management Inc. NY raised its position in shares of Becton, Dickinson and by 9.2% in the 1st quarter. QCI Asset Management Inc. NY now owns 710 shares of the medical instruments supplier’s stock valued at $130,000 after purchasing an additional 60 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in shares of Becton, Dickinson and by 55.8% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock valued at $131,000 after purchasing an additional 240 shares in the last quarter. Finally, Financial Architects Inc raised its position in shares of Becton, Dickinson and by 8.0% in the 2nd quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock valued at $142,000 after purchasing an additional 54 shares in the last quarter. 87.12% of the stock is currently owned by hedge funds and other institutional investors.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The company had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.06 billion. During the same quarter last year, the company earned $2.35 EPS. The company’s quarterly revenue was down 5.1% on a year-over-year basis.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 29th. Shareholders of record on Friday, September 8th were given a $0.73 dividend. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.47%. Becton, Dickinson and’s dividend payout ratio is currently 83.43%.

In other Becton, Dickinson and news, insider Gary M. Cohen sold 15,512 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $203.77, for a total value of $3,160,880.24. Following the completion of the sale, the insider now owns 95,781 shares in the company, valued at approximately $19,517,294.37. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Linda M. Tharby sold 4,695 shares of the firm’s stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $200.48, for a total value of $941,253.60. Following the completion of the sale, the executive vice president now owns 18,670 shares of the company’s stock, valued at approximately $3,742,961.60. The disclosure for this sale can be found here. Insiders sold a total of 75,904 shares of company stock valued at $15,242,688 in the last quarter. Corporate insiders own 1.40% of the company’s stock.

A number of brokerages have issued reports on BDX. Barclays PLC reaffirmed an “equal weight” rating and issued a $210.00 target price (up from $205.00) on shares of Becton, Dickinson and in a research report on Thursday, August 10th. BidaskClub lowered Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $213.00 target price on shares of Becton, Dickinson and in a research report on Tuesday, September 12th. Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. Finally, Zacks Investment Research lowered Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Monday, August 7th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $200.93.

ILLEGAL ACTIVITY NOTICE: “PNC Financial Services Group Inc. Sells 16,651 Shares of Becton, Dickinson and Company (BDX)” was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international trademark and copyright law. The original version of this piece of content can be read at https://sportsperspectives.com/2017/10/13/pnc-financial-services-group-inc-sells-16651-shares-of-becton-dickinson-and-company-bdx.html.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply